ABSTRACTS RULES
Instructions
The deadline for abstracts’ submission is July 17, 2025.
- Abstracts must be in English.
- Only abstracts that contain original data will be accepted.
- Abstracts containing data that have been presented or will be presented at a different scientific meeting can be submitted, but this information must be provided in the submission form.
- There are no restrictions for abstracts pending publication acceptance by the time of the submission process.
- Abstracts that report work that has been accepted for publication as a manuscript (e.g., full-length article, brief report, case report, concise communication or letter to the editor, etc.) prior to the submission deadline, are ineligible for consideration.
- It is necessary that one of the authors, either responsible for submission or presentation, be registered at the event. Payment is not required at the moment of submission; this can be done within 7 days after receiving the acceptance letter.
- By submitting the abstract, the authors assume compliance with the laws and ethical norms governing research with human beings and animals, including the approval by the ethics committees in research and clinical ethics in animal research.
- Omit all names and geographical references in the title and body of the abstract. If you must include geographical names (for example, to describe the patient population) use the most generic name possible. This will prevent the authorship of your abstract from being inadvertently identified during blinded peer review.
- The abstract must be submitted exclusively through the congress website (link at the end of this page).
- Before submitting the abstract, review it carefully. Changes will not be allowed after the submission deadline.
- All communication related to the abstract will be sent via email to the author responsible for the submission and the author responsible for presentation.
Results
- The abstract review process is blinded.
- The author responsible for the abstract’s submission, after obtaining its approval, needs to pay the registration fee within 7 days from acceptance letter.
- There will be no refund of the registration fee in cases of withdrawal of the abstract or absence in Congress;
- The presentation should preferably be made by the person responsible for submitting the abstract, although this is not mandatory. The final decision of the Evaluation Committee is considered supreme, irrevocable and unappealing, and will not be revised. Abstracts that are not accepted for oral presentation can be presented via poster and the authors will be informed of this decision.
- The certificate for the abstract presented will be issued. The certificate will be issued following the registered order of authors and sent to the authors;
- At least one of the authors must be enrolled, attend the event and present the abstract in order to receive the certificate;
- Please note: All materials produced from the submitted abstract (annals, certificates, among others) will be a faithful reproduction of the information submitted by the author. Therefore, it is not possible to make changes in the spelling of the title, abstract or authors after the abstracts’ submission deadline. The information provided is the sole responsibility of the author who submit it.
Themes
- Antiphospholipid syndrome
- Autoinflammatory and Rare Diseases
- Bioethics, Education and Information Management
- Clinical Laboratory Techniques
- Complementary and alternative Therapies
- Crystal-related and metabolic Arthropathies
- Epidemiology, Public health, Economics
- Fibromyalgia and pain syndromes
- Imaging in Rheumatology
- Infections and rheumatic diseases
- Muscular Diseases
- Orthopedics, Soft-tissue rheumatisms, Low back pain
- Osteoarthritis
- Osteoporosis and Metabolic Bone Diseases
- Pediatrics
- Procedures in Rheumatology
- Rehabilitation
- Rheumatic manifestations related to systemic diseases
- Rheumatoid Arthritis
- Sjögren’s Syndrome
- Spondyloarthritis
- Systemic Lupus Erythematosus
- Systemic Scleroderma
- Vasculitis
- Health Technology and Digital Health
Submission
The deadline for abstracts’ submission is July 17, 2025.
- Abstracts must be submitted in English.
- The title should be concise, reflect the study to be presented and be typed in the appropriate field of the submission form as well as in the attached file.
- There is no limit of authors per paper.
- The presenter must also be on the author’s list;
- The abstract´s body text should not exceed 400 words (excluding the title, authorship and affiliations), and the title should not exceed 250 characters including spaces.
- The abstract of original research must be presented in the following sequence: background/methods/results/conclusion; This suggestion does not apply to case reports/clinical trials.
- The abstracts of case reports must be presented in the following sequence: background/case report/conclusion. Bibliographical references should not be included in case reports. Whereas case reports contribute to the exchange of experience among professionals, the Evaluation Committee recommends to be submitted only reports of atypical features of common cases or of extraordinarily rare conditions, considering their clinical relevance;
- The contents of the abstracts should be related to the chosen theme.
- Tables and figures will be accepted:
- Tables: tables must be numbered (e.g. Table 1) with a short descriptive title. The tables MUST be quoted/mentioned in the text. The words in the table will be counted as part of the 400 allowed for the abstract.
- Figures: Figures and illustrations must be numbered (e.g. Figure 1) with a short descriptive title. The figures MUST be quoted/mentioned in the text. You need permission to use identifiable pictures, even when eyes are covered. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of pictures may not be required. If needed, a permission form is available for download below:
English version
Versão em Português
- Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures (or tables) that have previously been published elsewhere. In order for all figures to be open access, authors must have permission from the rights holder if they wish to include images that have been published elsewhere in non-open access journals. Permission should be indicated in the legend, and the original source included in the reference list.
- Results based on statements such as "results will be displayed" and/or "data will be parsed" will not be considered. They should be exposed as clearly as possible, and the conclusions should be based on the data presented.
- Case reports without clear originality and/or relevance justifying their presentation will not be accepted. Studies that present only a literature review, except systematic literature reviews, will also be refused.
- Trade names are not allowed; only generic names of drugs, written in lowercase letters.
- References, acknowledgements and financial assistance are not mandatory and, if included, must be computed as part of the abstract and be included the end with no identifiable information.
SUBMIT AN ABSTRACT
Awards
You may also submit separately your paper as a manuscript to one of the awards. Please check the awards page for instructions and link.
Instructions and link for abstract submission are different from a manuscript submitted to the awards:
- To submit an abstract for oral or poster presentation, use the instructions/link of the current page.
- To submit a manuscript to one of the awards, use the instructions/link described in the awards page.
